Presented through a collaboration between American Gastroenterological Association (AGA) and Medscape Education.
OVERVIEW
The treatment landscape for inflammatory bowel disease (IBD) is changing rapidly. Novel pharmacologic agents with different and unique mechanisms of action that target specific steps in the IBD disease pathway represent significant advances in the treatment of Crohn’s disease and ulcerative colitis. In this live symposium, IBD clinician experts will discuss and differentiate these new and emerging therapies, provide context for their use in clinical practice, and use patient cases to illustrate evolving concepts in risk stratification and treat-to-target approaches. Faculty will also discuss nuances in treatment selection for complex patients and the latest guidance on therapeutic drug monitoring.
GOAL STATEMENT
The goal of this activity is for learners to be better able to incorporate new targeted treatments for IBD into practice, including individualizing treatment.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [list][item]Mechanisms of action of newer targeted treatments for IBD [item]Clinical data on newer targeted IBD treatments [/list]Have greater competence related to: [list][item]Recommending evidence-based IBD treatments that consider patients’ comorbid conditions [item]Utilizing appropriate laboratory monitoring prior to and during treatment with newer targeted IBD agents [/list] Greater confidence in their ability to [list][item]Incorporate new targeted agents for IBD into treatment strategies
ACCREDITATION STATEMENT
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
[bold]For Physicians[/bold] The AGA Institute designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credits™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Gaylord Rockies Resort & Convention Center
AURORA D
6700 N Gaylord Rockies Blvd
Aurora, Colorado, 80019
United States
This program is not affiliated with the Crohn's and Colitis Congress®.
Supported by an independent educational grant from [bold]AbbVie[/bold].